Hideyuki Saya

Toyoake, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 267 publications

Post-transcriptional regulation of mRNA stability in pancreatic ductal adenocarcinoma.

Post-transcriptional regulation of mRNA stability in pancreatic ductal adenocarcinoma.

Journal: Frontiers in immunology
Published: April 21, 2026

Proof-of-Concept of a DNA-Based Recording System for High-Throughput Functional Gene Screening.

Proof-of-Concept of a DNA-Based Recording System for High-Throughput Functional Gene Screening.

Journal: ACS synthetic biology
Published: April 15, 2026

Genomic Alteration Patterns Across Histological Grades in BRAF p.V600E-Mutant Gliomas and Glioneuronal Tumors: An Analysis of 15 Cases.

Genomic Alteration Patterns Across Histological Grades in BRAF p.V600E-Mutant Gliomas and Glioneuronal Tumors: An Analysis of 15 Cases.

Journal: Pathology international
Published: February 15, 2026

Pazopanib for recurrent central nervous system solitary fibrous tumors: A single-institution retrospective series.

Pazopanib for recurrent central nervous system solitary fibrous tumors: A single-institution retrospective series.

Journal: Clinical neurology and neurosurgery
Published: January 24, 2026

Rapid Drug Sensitivity Profiling via a Novel High-Success-Rate Culture Method for Patient-Derived Pancreatic Cancer: An Exploratory Preclinical Platform for Advancing Clinical Applications and Drug Development.

Rapid Drug Sensitivity Profiling via a Novel High-Success-Rate Culture Method for Patient-Derived Pancreatic Cancer: An Exploratory Preclinical Platform for Advancing Clinical Applications and Drug Development.

Journal: Cells
Published: January 09, 2026

Identification of BRCA2 Likely Germline Pathogenic Variants in Patients with Multiple Primary Lung Adenocarcinomas.

Identification of BRCA2 Likely Germline Pathogenic Variants in Patients with Multiple Primary Lung Adenocarcinomas.

Journal: Oncology research
Published: December 29, 2025

Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin-Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial.

Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin-Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial.

Journal: JMIR research protocols
Published: November 17, 2025

Feasibility of long-read nanopore sequencing for methylation-based classification of posterior fossa ependymomas.

Feasibility of long-read nanopore sequencing for methylation-based classification of posterior fossa ependymomas.

Journal: Brain tumor pathology
Published: October 07, 2025

Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy.

Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy.

Journal: Cancer science
Published: September 14, 2025

Depleting HIF‑1α attenuates the progression of osteosarcoma, but tumorigenicity is sustained through HIF‑independent pathways.

Depleting HIF‑1α attenuates the progression of osteosarcoma, but tumorigenicity is sustained through HIF‑independent pathways.

Journal: Oncology reports
Published: September 10, 2025

Targeting distinct amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas.

Targeting distinct amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas.

Journal: Acta neuropathologica communications
Published: August 11, 2025

Establishment of a Large-Scale PDX Library of Head and Neck Cancers for Functional Precision Oncology.

Establishment of a Large-Scale PDX Library of Head and Neck Cancers for Functional Precision Oncology.

Journal: Cancer medicine
Published: July 31, 2025
Showing 1-12 of 267

Last Updated: 09/26/2026